Search results
Results from the WOW.Com Content Network
Maddox wing. The Maddox Wing is an instrument utilized by ophthalmologists, orthoptists and optometrists in the measurement of strabismus (misalignment of the eyes; commonly referred to as a squint or lazy eye by the lay person). It is a quantitative and subjective method of measuring the size of a strabismic deviation by dissociation of the ...
Heterophoria is an eye condition in which the directions that the eyes are pointing at rest position, when not performing binocular fusion, are not the same as each other, or, "not straight". This condition can be esophoria, where the eyes tend to cross inward in the absence of fusion; exophoria, in which they diverge; or hyperphoria, in which ...
TNM is a notation system that describes the stage of a cancer, which originates from a solid tumor, using alphanumeric codes: M describes distant metastasis (spread of cancer from one part of the body to another). The TNM staging system for all solid tumors was devised by Pierre Denoix between 1943 and 1952, using the size and extension of the ...
Determining the extent to which a cancer has developed. Cancer staging is the process of determining the extent to which a cancer has grown and spread. A number from I to IV is assigned, with I being an isolated cancer and IV being a cancer that has metastasized and spread from its origin. The stage generally takes into account the size of a ...
Exophoria. Exophoria is a form of heterophoria in which there is a tendency of the eyes to deviate outward. [1] During examination, when the eyes are dissociated, the visual axes will appear to diverge away from one another. [2] The axis deviation in exophoria is usually mild compared with that of exotropia .
Historically only one randomised clinical trial has addressed optimal dosage, allocated patients to two dosage levels, stratified by risk, but showed no difference in cancer control between the low and high doses (63 and 68.4 Gy), but a higher incidence of complications at the higher doses. Consequently, the lower dose of 57.6 Gy was recommended.
June 24, 2024 at 7:14 AM. (Reuters) - G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial. G1 ...
Barrett's esophagus is a condition in which there is an abnormal ( metaplastic) change in the mucosal cells lining the lower portion of the esophagus, from stratified squamous epithelium to simple columnar epithelium with interspersed goblet cells that are normally present only in the small intestine and large intestine.